This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow P3Rs: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Biederman, J.
Right arrow Articles by Faraone, S. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Biederman, J.
Right arrow Articles by Faraone, S. V.
Related Collections
Right arrow Neurology & Psychiatry

PEDIATRICS Vol. 104 No. 2 August 1999, p. e20

ELECTRONIC ARTICLE:
Pharmacotherapy of Attention-deficit/Hyperactivity Disorder Reduces Risk for Substance Use Disorder

Received Dec 18, 1998; accepted Mar 19, 1999.

Joseph Biederman*, §, Timothy Wilens*, Eric Mick*, Dagger , Thomas Spencer*, and Stephen V. Faraone*, §

From the * Pediatric Psychopharmacology Unit, Massachusetts General Hospital; Dagger  Department of Epidemiology, Harvard School of Public Health; and § Harvard Medical School, Boston, Massachusetts.

Objective.  To assess the risk for substance use disorders (SUD) associated with previous exposure to psychotropic medication in a longitudinal study of boys with attention-deficit/hyperactivity disorder (ADHD).

Methods.  The cumulative incidence of SUD throughout adolescence was compared in 56 medicated subjects with ADHD, 19 nonmedicated subjects with ADHD, and 137 non-ADHD control subjects.

Results.  Unmedicated subjects with ADHD were at a significantly increased risk for any SUD at follow-up compared with non-ADHD control subjects (adjusted OR: 6.3 [1.8-21.6]). Subjects with ADHD medicated at baseline were at a significantly reduced risk for a SUD at follow-up relative to untreated subjects with ADHD (adjusted OR: 0.15 [0.04-0.6]). For each SUD subtype studied, the direction of the effect of exposure to pharmacotherapy was similar to that seen for the any SUD category.

Conclusions.  Consistent with findings in untreated ADHD in adults, untreated ADHD was a significant risk factor for SUD in adolescence. In contrast, pharmacotherapy was associated with an 85% reduction in risk for SUD in ADHD youth.  Key words:  ADHD, pharmacotherapy substance use disorders.




This article has been cited by other articles:


Home page
 EDUCATION AND PRACTICEHome page
V A Harpin
Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006
Arch. Dis. Child. Ed. Pract., April 1, 2008; 93(2): 58 - 65.
[Abstract] [Full Text] [PDF]

Home page
 Alcohol AlcoholHome page
M. D. Ohlmeier, K. Peters, B. T. T. Wildt, M. Zedler, M. Ziegenbein, B. Wiese, H. M. Emrich, and U. Schneider
Comorbidity of Alcohol and Substance Dependence with Attention-Deficit/Hyperactivity Disorder (ADHD)
Alcohol Alcohol., March 7, 2008; (2008) agn014v1.
[Abstract] [Full Text] [PDF]

Home page
 J Atten DisordHome page
A. L. Rostain and J. R. Ramsay
A Combined Treatment Approach for Adults With ADHD--Results of an Open Study of 43 Patients.
J Atten Disord, November 1, 2006; 10(2): 150 - 159.
[Abstract] [PDF]

Home page
 J PsychopharmacolHome page
H. Ashton, P. Gallagher, and B. Moore
The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder
J Psychopharmacol, September 1, 2006; 20(5): 602 - 610.
[Abstract] [PDF]

Home page
 Am J Health Syst PharmHome page
J. A. Dopheide
ASHP Therapeutic Position Statement on the Appropriate Use of Medications in the Treatment of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients
Am. J. Health Syst. Pharm., July 15, 2005; 62(14): 1502 - 1509.
[Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
V A Harpin
The effect of ADHD on the life of an individual, their family, and community from preschool to adult life
Arch. Dis. Child., February 1, 2005; 90(suppl_1): i2 - i7.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
J. GILLIGAN and B. LEE
The Psychopharmacologic Treatment of Violent Youth
Ann. N.Y. Acad. Sci., December 1, 2004; 1036(1): 356 - 381.
[Abstract] [Full Text] [PDF]

Home page
 Fam PractHome page
K Shaw, I Wagner, H Eastwood, and G Mitchell
A qualitative study of Australian GPs' attitudes and practices in the diagnosis and management of attention-deficit/hyperactivity disorder (ADHD)
Fam. Pract., April 1, 2003; 20(2): 129 - 134.
[Abstract] [Full Text] [PDF]

Home page
 Adv. Psychiatr. Treat.Home page
D. Coghill
Current issues in child and adolescent psychopharmacology. Part 1: Attention-deficit hyperactivity and affective disorders
Advan. Psychiatr. Treat., March 1, 2003; 9(2): 86 - 94.
[Abstract] [Full Text] [PDF]

Home page
 J Learn DisabilHome page
N. Z. Weinberg
Risk Factors for Adolescent Substance Abuse
J Learn Disabil, July 1, 2001; 34(4): 343 - 351.
[Abstract] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
D. J. MARKS, J. H. NEWCORN, and J. M. HALPERIN
Comorbidity in Adults with Attention-Deficit/Hyperactivity Disorder
Ann. N.Y. Acad. Sci., June 1, 2001; 931(1): 216 - 238.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. A. SULLIVAN and F. RUDNIK-LEVIN
Attention Deficit/Hyperactivity Disorder and Substance Abuse: Diagnostic and Therapeutic Considerations
Ann. N.Y. Acad. Sci., June 1, 2001; 931(1): 251 - 270.
[Abstract] [Full Text] [PDF]

Home page
 Trauma Violence AbuseHome page
M. H. MULSOW, K. K. O'NEAL, and V. M. MURRY
Adult Attention Deficit Hyperactivity Disorder, the Family, and Child Maltreatment
Trauma Violence Abuse, January 1, 2001; 2(1): 36 - 50.
[Abstract] [PDF]

P3Rs:

Read all P3Rs

small error
Richard Brozovich
Pediatrics Online, 6 Nov 1999 [Full text]
Response to Dr. Brozovich''s query
Eric Mick
Pediatrics Online, 15 Nov 1999 [Full text]